Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 23, 2026
Validation of International Classification of Diseases (ICD) code-based case definitions of immune checkpoint inhibitor associated inflammatory arthritis from administrative health data
Manar Elsayed, Zoe Hsu, Finlay A McAlister, et al.
The Journal of Rheumatology
|
December 16, 2024
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, et al.
The Journal of Rheumatology
|
August 1, 2023
An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists
Hengameh Kheirkhah, Nicole M S Hartfeld, Jessica Widdifield, et al.
ACR Open Rheumatology
|
February 18, 2025
Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology Database
Alexandra Ladouceur, Shahin Jamal, Alexandra Saltman, et al.
Cancer Immunology, Immunotherapy : CII
|
January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology
Sabrina Hoa, Linda Laaouad, Janet Roberts, et al.
The Journal of Rheumatology
|
February 2, 2022
Results From the 2020 Canadian Rheumatology Association's Workforce and Wellness Survey
Stephanie C Kulhawy-Wibe, Jessica Widdifield, Jennifer J Y Lee, et al.
The Journal of Rheumatology
|
September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases
Carrie Ye, Roko P A Nikolic, May Choi, et al.
The Journal of Rheumatology
|
September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides
Carrie Ye, Roko P A Nikolic, May Choi, et al.
Systematic Reviews
|
February 13, 2019
Inappropriateness of health care in Canada: a systematic review protocol
Janet E Squires, Ian D Graham, Doris Grinspun, et al.
Journal of the American Academy of Dermatology
|
February 28, 2004
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris
James Leyden, Wilma Bergfeld, Lynn Drake, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 23, 2026
Validation of International Classification of Diseases (ICD) code-based case definitions of immune checkpoint inhibitor associated inflammatory arthritis from administrative health data
Manar Elsayed, Zoe Hsu, Finlay A McAlister, et al.
The Journal of Rheumatology
|
December 16, 2024
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, et al.
The Journal of Rheumatology
|
August 1, 2023
An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists
Hengameh Kheirkhah, Nicole M S Hartfeld, Jessica Widdifield, et al.
ACR Open Rheumatology
|
February 18, 2025
Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology Database
Alexandra Ladouceur, Shahin Jamal, Alexandra Saltman, et al.
Cancer Immunology, Immunotherapy : CII
|
January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology
Sabrina Hoa, Linda Laaouad, Janet Roberts, et al.
The Journal of Rheumatology
|
February 2, 2022
Results From the 2020 Canadian Rheumatology Association's Workforce and Wellness Survey
Stephanie C Kulhawy-Wibe, Jessica Widdifield, Jennifer J Y Lee, et al.
The Journal of Rheumatology
|
September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases
Carrie Ye, Roko P A Nikolic, May Choi, et al.
The Journal of Rheumatology
|
September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides
Carrie Ye, Roko P A Nikolic, May Choi, et al.
Systematic Reviews
|
February 13, 2019
Inappropriateness of health care in Canada: a systematic review protocol
Janet E Squires, Ian D Graham, Doris Grinspun, et al.
Journal of the American Academy of Dermatology
|
February 28, 2004
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris
James Leyden, Wilma Bergfeld, Lynn Drake, et al.
Page
of 4